Tag Archives: buy

Amaya Inc joins battle to buy Bwin.party


GVC Holdings Plc, a London-listed gambling online company, is teaming up with Canadian gaming titan Amaya Inc. in its effort to get Bwin.party Digital Entertainment Plc and thwart an adversary bid from 888 Holdings Plc. The possible takeover of Bwin.party by GVC, announced May 15, would be financed jointly with Amaya, the Isle of Man-based company said in a statement ...

Read More »

Buy Canada back in vogue as foreign investment in securities jumps most since May 2012


OTTAWA – Foreign investment in Canadian securities jumped to $22.47 billion in March, the biggest inflow since May 2012, as investors acquired corporate bonds and stocks, data from Statistics Canada showed on Friday. Non-residents invested $20.96 billion in Canadian bonds, reflecting strong new issue activity. Investors purchased $17.03 billion in Canadian corporate bonds, the highest since October 2001. Canadian investors ...

Read More »

The best 11 Canadian stocks to buy in June


We asked our top analysts for his or her favourite stocks to purchase this month. Kay Ng: Canadian Western Bank (TSX:CWB) Canadian Western Bank (TSX:CWB) remains my top idea from recently. Canadian Western is really a regional bank offering personal and business banking services over the four western provinces. It\’s even cheaper than last month, dropping from $31 to $28. ...

Read More »

Intel Corp to buy Altera Corp in US$16.7-billion deal


Intel Corp agreed to buy Altera Corp for US$16.7 billion as the world\’s biggest chipmaker seeks to make up for slowing demand in the PC industry by expanding its line-up of higher-margin chips utilized in data centres. By combining with Altera, Intel can bundle its processing chips with the smaller company\’s programmable chips, that are used, amongst other things, to ...

Read More »

Buy Lundin now, HudBay later: Desjardins


Lundin Mining Corp. and HudBay Minerals Inc. are generally copper miners and have similar market caps. Lots of investors buy both stocks in tandem when they want copper exposure, but Desjardins Securities analyst Jackie Przybylowski offers another strategy. “While Lundin remains attractively valued and it has the best possibility of positive stock price catalysts soon, early 2016 could present a ...

Read More »

Gran Tierra Energy Inc upgraded to buy


Gran Tierra Energy Inc. was upgraded to purchase from hold at Canaccord Genuity as a result of its renewed capital resolve for Colombia. Analyst Christopher Brown also raised his price target on Gran Tierra shares to $5 from $4, hoping that the company’s new management team will fulfill their promises to shareholders. West Face Capital’s successful shake-up of Gran Tierra’s ...

Read More »

Aetna Inc to buy Humana Inc for $37 billion in largest insurance deal ever


Health insurer Aetna Inc said it would buy smaller rival Humana Inc for around $37 billion in cash and stock, within the largest ever deal in the insurance industry. The combination will push Aetna close to Anthem Inc\’s No.2 insurer spot by membership, and would nearly triple Aetna\’s Medicare Advantage business. The deal will face antitrust scrutiny but when it ...

Read More »

TIO’s Softgate buy seen as transformational


TIO Networks Corp.’s announced acquisition of Softgate Systems Inc. won’t likely close for some more months, but it won’t hurt if investors in TIO, a cloud-based bill payment processor, wish to start adding to their holdings ahead of time, says Kris Thompson, analyst at National Bank Financial. “The stock will likely not rally an excessive amount of more ahead of ...

Read More »

CCL Industries’ growth prospects label it a buy


CCL Industries Inc. continues to be labelled a \”great investment opportunity\” by Neil Linsdell, analyst at Industrial Alliance Securities. Linsdell, who took control of coverage of the specialty packaging company at the end of May, tagged the stock with a strong buy rating and $195 price target, addressing a 20-per-cent upside to CCL\’s current stock price near $163. \”CCL has ...

Read More »

Celgene Corp to buy Receptos Inc for US$7.2 billion


Celgene Corp said it decided to buy Receptos Inc for about $7.2 billion to grow its pipeline with Receptos\’ immune-inflammatory bowel drug, Ozanimod. Celgene will pay US$232 in cash for each Receptos share, representing a 12 per cent premium to the company\’s closing price on Tuesday. Ozanimod is in late-stage trials for inflammatory bowel disease and ms. Related What Valeant\’s ...

Read More »